Skip to main content
. Author manuscript; available in PMC: 2018 Apr 19.
Published in final edited form as: Invest New Drugs. 2015 Oct 21;33(6):1225–1231. doi: 10.1007/s10637-015-0298-3

Table 1.

Dose escalation table

Dose level BKM120
(mg daily)
100 % mFOLFOX6
(D1, D15)
Total patients Number of evaluable
patients for DLT
Number of patients
with DLT
1 40 Oxaliplatin: 85 mg/m2 4 3 0
Leucovorin: 400 mg/m2
5-FU bolus: 400 mg/m2
5-FU infusion: 2400 mg/m2
2 60 Oxaliplatin: 85 mg/m2 10 8 4
Leucovorin: 400 mg/m2 Hyperglycemia (grade 3)
5-FU bolus: 400 mg/m2 AST/ALT elevation (grade 3)
5-FU infusion: 2400 mg/m2 neutropenia (grade 4)
febrile neutropenia (grade 4)
thrombocytopenia (grade 4)
3 80 Oxaliplatin: 85 mg/m2 3 2 1
Leucovorin: 400 mg/m2 neutropenia (grade 4)
5-FU bolus: 400 mg/m2
5-FU infusion: 2400 mg/m2
HHS Vulnerability Disclosure